Remission of Behçet's syndrome with tumour necrosis factor alpha blocking therapy.
Goossens
P H
PH
Department of Rheumatology, Leiden University Medical Centre, The Netherlands.
Verburg
R J
RJ
Breedveld
F C
FC
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001528:Behcet Syndrome / Q000628:therapy*; D006801:Humans; D000069285:Infliximab; D008297:Male; D010409:Penile Diseases / Q000628:therapy; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000276:immunology*; D014456:Ulcer / Q000628:therapy
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab